Chemfab Alkalis Commissions New INEOS Electrolyser With ₹57 Crore Investment, Targets Efficiency Gains From Q4 FY26

1767679210427.webp
Chennai, January 6, 2026 Chemfab Alkalis Limited (NSE: CHEMFAB | BSE: 541269) has successfully commissioned a latest-generation INEOS Electrolyser, replacing its nearly three-decade-old second-generation UHDE electrolyser and associated equipment, marking a significant upgrade in its chlor-alkali manufacturing infrastructure.

The newly commissioned electrolyser is expected to improve overall operational efficiency, enhance reliability, and optimise power consumption across the company’s production operations. The upgrade represents a strategic move aimed at strengthening process stability while reducing operating costs over the medium term.

Capacity and Operational Impact​

Despite the equipment replacement, the company’s approved production capacity remains unchanged at 180 tonnes per day, ensuring continuity in output levels while benefiting from improved technology. Management expects the upgraded system to support higher operating rates and deliver measurable power savings beginning Q4 of FY26.

Capital Expenditure Details​

The total capital expenditure incurred for the electrolyser replacement project stands at approximately ₹57 crore. The investment has been fully funded through internal accruals, reflecting a conservative balance-sheet approach and avoiding additional leverage.

About the Company​

Chemfab Alkalis Limited is a listed Indian chemical manufacturer primarily engaged in the production of chlor-alkali products. The company operates manufacturing facilities in southern India and caters to a wide range of industrial customers across sectors such as textiles, paper, alumina, soaps and detergents, and water treatment. Shares of the company are listed on both the NSE and BSE.

Source:
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top